| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |